Clinical trial · Observational
EUS Procedures Using RIVOS™ EUS Access Device
Registry of Patients Undergoing Endoscopic Ultrasound (EUS) Procedures Using the RIVOS™ EUS Access Device
NCT07696572CI-TRIAL-00117530recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biliary Obstruction | — | UNRESOLVED | — |
| Chronic Pancreatitis | — | UNRESOLVED | — |
| Pancreatic Cancer Non-resectable | — | UNRESOLVED | — |
| Pancreatic Duct Obstruction | — | UNRESOLVED | — |
| Pancreatic Fluid Collections | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EUS-guided intervention using the RIVOS™ EUS access device | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients requiring interventional EUS procedures
- description
- Patients requiring interventional EUS procedures
- interventionNames
- Device: EUS-guided intervention using the RIVOS™ EUS access device
Primary outcomes (1)
- measure
- Technical success
- timeFrame
- 1 day
- description
- Rate of technical success in patients undergoing EUS-guided procedures
Secondary outcomes (4)
- measure
- Treatment success
- timeFrame
- 4 weeks
- description
- Rate of treatment success, defined as the resolution of symptoms and/or radiological findings from underlying disease at 4-weeks following index intervention.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years * All patients undergoing EUS-guided interventions using the RIVOS™ EUS access device Exclusion Criteria: * Age \< 18 years * Patients who did not undergo EUS-guided interventions using the RIVOS™ EUS access device
References
Publications (0)
Data not yet available
No reference posted for this study.